Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers
NCT04223544 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2020-01-10
Summary
The main aim of research is to determine of the prevalence of influenza virus and influenza vaccination coverage rate among hospital and GPs healthcare workers.
Course of research:
Participation in the study is voluntary and carried out after the consent of the examined person. The examination consists of: 1) completing the questionnaire and 2) taking the throat swab twice by the researcher. Two throat swab samples will be taken at the same time. Both samples will be used for virological examination to determine the presence of influenza virus material using non-invasive tests: one sample will be analyzed by a quick 'on-site' test - Flu SensDx kit, while the other sample will be transported to the laboratory, where the reverse transcriptase polymerase chain reaction (RT-PCR) - reference method - will be performed to confirm the presence of influenza genetic material. Swabs are planned to be collected during the 2019/2020 influenza epidemic season (January-March).
In the last stage of the study, the results obtained from the survey questionnaire and the results of virological tests will be subject to statistical analysis and based on the data obtained, conclusions will be drawn from the study, indicating their practical application.
The results obtained from this study will be used to develop a quality improvement program to control influenza virus infection, which will improve the safety of both patients and medical staff.
Conditions
- Influenza
- Vaccination
- Attitude of Health Personnel
Interventions
- DIAGNOSTIC_TEST
-
Influenza POC and laboratory testing
Participation in the study is voluntary and carried out after the consent of the examined person. The examination consists of: 1) completing the questionnaire and 2) taking the throat swab twice by the researcher. Two throat swab samples will be taken at the same time. Both samples will be used for virological examination to determine the presence of influenza virus material using non-invasive tests: one sample will be analyzed by a quick 'on-site' test - Flu SensDx kit, while the other sample will be transported to the laboratory, where the reverse transcriptase polymerase chain reaction (RT-PCR) - reference method - will be performed to confirm the presence of influenza genetic material. Swabs are planned to be collected during the 2019/2020 influenza epidemic season (January-March).
Sponsors & Collaborators
-
Wroclaw Medical University
lead OTHER
Principal Investigators
-
Michal Jedrzejek · Family Medicine Department of Wroclaw Medical University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-13
- Primary Completion
- 2020-04-03
- Completion
- 2020-04-03
Countries
- Poland
Study Locations
More Related Trials
-
Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza
NCT00833885 ·Status: COMPLETED ·Phase: NA
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Evaluation of the Effectiveness of a Flu Vaccination Campaign for Healthcare Workers of a Teaching Hospital: a Pre-post Study
NCT05783713 ·Status: COMPLETED
-
Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants
NCT06800885 ·Status: COMPLETED
-
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting
NCT02478905 ·Status: COMPLETED
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers
NCT01481467 ·Status: UNKNOWN ·Phase: NA
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Viral Challenge Study of CC-42344 in Healthy Participants
NCT06160531 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Influenza Vaccination of Healthcare Workers (HCW) on the Risk of Influenza in Patients Hospitalized in Short Stays Units
NCT02198638 ·Status: COMPLETED ·Phase: NA
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 ·Status: COMPLETED
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
NCT01144299 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes
NCT00992511 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
A/H1N1 Immunogenicity and Safety in Adults
NCT00959465 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Realization of the Recommendation for Influenza Vaccination in Pregnant Women
NCT03007797 ·Status: COMPLETED
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil
NCT01171157 ·Status: TERMINATED
-
Influenza 2020/2021
NCT04546854 ·Status: COMPLETED ·Phase: NA
-
Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.
NCT01063608 ·Status: COMPLETED ·Phase: PHASE4
-
Asymptomatic Flu Project
NCT02868658 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2